Investigating the effect of cyproheptadine in chronic kidney patients
Phase 3
- Conditions
- Chronic kidney patients undergoing hemodialysis.Chronic kidney disease, stage 5N18.5
- Registration Number
- IRCT20220329054368N2
- Lead Sponsor
- Yasouj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 124
Inclusion Criteria
Chronic kidney patients undergoing dialysis between 18 and 80 years of age, at least three months have passed since the start of dialysis.
Patients who undergo dialysis twice a week with good efficacy.
People's willingness to participate in the project.
Absence of accompanying disease (infection, uncompensated heart failure, malignancy, liver cirrhosis, covid-19) that causes the patient's anorexia.
Not taking drugs such as tricyclic antidepressants and corticosteroids that increase appetite.
Exclusion Criteria
Patient migration or death
Dissatisfaction with the continuation of treatment by the patient.
If other infectious or chronic diseases occur during the research period.
Patients who underwent organ transplant surgery.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Appetite. Timepoint: Before and three months after the intervention. Method of measurement: NMA questionnaire.;Anthropometric indicators. Timepoint: Before and three months after the intervention. Method of measurement: Meter.;Laboratory indicators. Timepoint: Before and three months after the intervention. Method of measurement: cycmax.
- Secondary Outcome Measures
Name Time Method